⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14612409 | 0.79 | — | — | |
| SCHEMBL24833946 | 0.79 | HTT (0.52) | — | |
| SCHEMBL6300741 | 0.79 | HTT (0.58) | — | |
| SCHEMBL1157477 | 0.79 | HTT (0.58) | — | |
| Ammonia Solution, Strong SCHEMBL18151740 | 0.77 | HTT (0.56) | — | |
| SCHEMBL9799907 | 0.77 | — | — | |
| SCHEMBL1006550 | 0.76 | HTT (0.55) | — | |
| SCHEMBL4040047 | 0.75 | — | — | |
| SCHEMBL21034076 | 0.75 | — | — | |
| SCHEMBL22071792 | 0.75 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 97 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117039153-A | Functional non-aqueous electrolyte and lithium secondary battery | 广州天赐高新材料股份有限公司 | 2023-11-10 | — | — | CN | claimed |
| US-20060222997-A1 | Adhesion improver for photosensitive resin composition and photosensitive resin composition containing same | KOBAYASHI SATOSHI | 2006-10-05 | — | — | US | claimed |
| US-20260078114-A1 | COMPOUND USED AS INHIBITOR OF CDK4 KINASE AND USE THEREOF | TYK MEDICINES INC (CN) | 2026-03-19 | — | — | US | disclosed |
| WO-2025125665-A1 | FURTHER SUBSTITUTED IMIDAZOLES AS INHIBITORS OF NAV1.8 | Grünenthal GmbH (DE) | 2025-06-19 | — | — | WO | disclosed |
| WO-2024036170-A1 | ANTIBACTERIAL COMPOUNDS | BLACKSMITH MEDICINES, INC. (US) | 2024-02-15 | — | — | WO | disclosed |
| CN-109928971-B | Aryl substituted aminotetrahydropyrans and uses thereof | 广东东阳光药业股份有限公司 | 2024-01-16 | — | — | CN | disclosed |
| US-20230192761-A1 | COMPOUNDS AND METHODS FOR SELECTIVE C-TERMINAL LABELING | Quantum-Si Incorporated (US) | 2023-06-22 | — | — | US | disclosed |
| EP-3883037-B1 | ELECTROLYTE FOR LITHIUM SECONDARY BATTERY AND LITHIUM SECONDARY BATTERY INCLUDING THE SAME | LG ENERGY SOLUTION LTD (KR) | 2023-03-01 | — | — | EP | disclosed |
| EP-3080608-B1 | MASS LABELS | ELECTROPHORETICS LTD (GB) | 2023-02-01 | — | — | EP | disclosed |
| CN-110494219-B | Cyclically supported catalyst | 巴黎萨克雷大学 | 2022-10-28 | — | — | CN | disclosed |
| WO-2022104345-A1 | 1-(2-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YL)ACETYL)-4-HYDROXYPYRROLIDINE-2-CARBOXA|MIDE DERIVATIVES AS VHL INHIBITORS FOR THE TREATMENT OF ANEMIA | GENENTECH, INC. (US) | 2022-05-19 | — | — | WO | disclosed |
| EP-1054887-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | Amgen Inc. (US) | 2000-11-29 | — | — | EP | disclosed |
| EP-1000040-A1 | IL-5 INHIBITING 6-AZAURACIL DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 2000-05-17 | — | — | EP | disclosed |
| WO-1999059587-A1 | ANTI-VIRAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 1999-11-25 | — | — | WO | disclosed |
| WO-1999040091-A1 | BICYCLIC PYRIDINE AND PYRIMIDINE DERIVATIVES AS NEUROPEPTIDE Y RECEPTOR ANTAGONISTS | AMGEN INC. (US) | 1999-08-12 | — | — | WO | disclosed |
| WO-1999002505-A1 | IL-5 INHIBITING 6-AZAURACIL DERIVATIVES | JANSSEN PHARMACEUTICA N.V. (BE) | 1999-01-21 | — | — | WO | disclosed |
| US-5795869-A | IMMUNOLOGY AND PROTECTION AGAINST NEUROTOXICITY FOR NERVOUS SYSTEM DISORDERS | FIDIA S.P.A. (IT) | 1998-08-18 | — | — | US | disclosed |
| EP-0688331-A1 | NEW SULFATED LYSO-GANGLIOSIDE DERIVATIVES | FIDIA S.p.A. (IT) | 1995-12-27 | — | — | EP | disclosed |
| WO-1994020516-A1 | NEW SULFATED LYSO-GANGLIOSIDE DERIVATIVES | FIDIA S.P.A. (IT) | 1994-09-15 | — | — | WO | disclosed |
| US-4115060-A | LOW TEMPERATURE BLEACHING, DETERGENTS | FMC CORPORATION (US) | 1978-09-19 | — | — | US | disclosed |